RXO, Inc.
RXO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,180,542 | $2,718,419 | $2,002,080 | $2,444,400 |
| - Cash | $35,000 | $5,000 | $98,000 | $29,000 |
| + Debt | $664,000 | $558,000 | $617,000 | $135,000 |
| Enterprise Value | $3,809,542 | $3,271,419 | $2,521,080 | $2,550,400 |
| Revenue | $4,550,000 | $3,927,000 | $4,796,000 | $4,689,000 |
| % Growth | 15.9% | -18.1% | 2.3% | – |
| Gross Profit | $783,000 | $725,000 | $860,000 | $735,000 |
| % Margin | 17.2% | 18.5% | 17.9% | 15.7% |
| EBITDA | $117,000 | $134,000 | $209,000 | $272,000 |
| % Margin | 2.6% | 3.4% | 4.4% | 5.8% |
| Net Income | -$290,000 | $4,000 | $92,000 | $150,000 |
| % Margin | -6.4% | 0.1% | 1.9% | 3.2% |
| EPS Diluted | -2.17 | 0.034 | 0.79 | 1.29 |
| % Growth | -6,577.6% | -95.8% | -38.8% | – |
| Operating Cash Flow | -$12,000 | $89,000 | $310,000 | $155,000 |
| Capital Expenditures | -$45,000 | -$64,000 | -$57,000 | -$39,000 |
| Free Cash Flow | -$57,000 | $25,000 | $253,000 | $116,000 |